PDS Biotechnology PDSB

PDS Biotechnology Corp · Nasdaq · Pharmaceutical Preparations

$1.55+1.97%close on Oct. 29, 2026 · volume 8.1M · Yahoo Finance

Price, last 48 sessions

$0.50$1.00$1.50Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 29, 2026 · high $1.60 · low $0.20 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

No open-market insider buying or selling in the Form 4s filed since July 24, 2026.

Recent SEC filings

All 19 →
  • 4Oct. 21, 2026, 6:41 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 7:59 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

    AI summary, unreviewedPDS Biotechnology posts updated corporate presentation (Exhibit 99.1) with no new financial results, highlighting PDS0301 data and five readouts through Q2 2028

  • 4Oct. 20, 2026, 8:20 p.m. ETView on SEC.gov
  • 4Oct. 20, 2026, 8:20 p.m. ETView on SEC.gov
  • 8-KOct. 20, 2026, 8 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Other events · Financial statements and exhibits

    AI summary, unreviewedPDS Biotechnology Corp board overhaul: four directors resign, three pharma executives appointed, no financial results disclosed

  • 8-KOct. 6, 2026, 8:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • 8-KSept. 22, 2026, 8:05 a.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • SCHEDULE 13DSept. 21, 2026, 9:56 p.m. ETView on SEC.gov